OneMedNet CEO issues letter to shareholders

OneMedNet (ONMD) announced today that Aaron Green, President and CEO, issued the following letter to shareholders and other stakeholders of the Company: “Following a year of significant progress, OneMedNet is navigating 2025 with strong momentum, making substantial strides in expanding our market presence, enhancing our Real-World Data platform, and developing an AI driven tool set to anonymize and De-identify data across multiple industries… AI-Powered Platform: Our federated iRWD platform leverages cost-effective AI tools to search, de-identify, and curate precise datasets at scale… Expanded Market Reach: We are now partnered with five leading data marketplaces… Network Growth: Our partnerships with over 1,400 hospital and healthcare provider sites have grown… Amplified Brand Presence: Increased participation in industry trade shows and targeted campaigns has strengthened stakeholder engagement… Diverse Customer Base: Our healthcare regulatory-grade datasets are licensed by leading life sciences organizations for clinical trials, regulatory submissions, and AI model development, reflecting strong market validation. Regulatory Compliance: Our datasets meet stringent FDA and international standards… AI Innovation: We provide foundational data to train and validate AI models in medical imaging and diagnostics, accelerating advancements in precision medicine…. We have added a subscription-based Data License Agreement structure to drive Annual Recurring Revenue… Our three pillars-Platform, Partners, and People-anchor our strategy. Our proven AI de-identification and anonymization across industries, iRWD platform, growing network of provider sites, and experienced leadership team, with expertise in AI, cloud solutions, healthcare, regulatory compliance, and M&A, are aligned for execution.”